Comprehensive risk management for the prevention of cerebro-cardiovascular diseases in Japan Joint Committee for Comprehensive Risk Management Chart for the Prevention of Cerebro-Cardiovascular Diseases Report of the Committee 03 October 2017 Pages: 335 - 346
Ghrelin and exercise: a possible virtuous circle Yuji Tajiri Commentary 09 August 2017 Pages: 347 - 349
Effect of antihyperglycemic drug monotherapy to prevent the progression of mild hyperglycemia in early type 2 diabetic patients: the Japan Early Diabetes Intervention Study (JEDIS) Shoji KawazuYasunori KanazawaThe JEDIS (Japan Early Diabetes Intervention Study) Research Group Original Article 18 April 2017 Pages: 350 - 365
Loss of skeletal muscle mass and its predictors in type 2 diabetes patients under a multifaceted treatment approach Norihiko OharaIsao MinamiYoshihiro Ogawa Original Article 13 July 2017 Pages: 366 - 374
Design of and rationale for the Japan Diabetes compREhensive database project based on an Advanced electronic Medical record System (J-DREAMS) Takehiro SugiyamaKengo MiyoHiroshi Kajio Original Article 27 June 2017 Pages: 375 - 382
Effects of switching to low-dose rosuvastatin (5 mg/day) on glucose metabolism and lipid profiles in Japanese patients with type 2 diabetes and dyslipidemia: a single-arm, prospective, interventional trial Akiko KamedaAkinobu NakamuraYasuo Terauchi Original Article 05 July 2017 Pages: 383 - 391
A pilot study of short-term toe resistance training in patients with type 2 diabetes mellitus Hiroaki KataokaNobuyuki MiyatakeSatoshi Tanaka Short Communication 29 March 2017 Pages: 392 - 396
Different effects of linagliptin and sitagliptin on blood pressure and renal function in Japanese patients with type 2 diabetes mellitus Masayuki TojikuboYuji Tajiri Short Communication 24 April 2017 Pages: 397 - 401
